Arginine vasopressin deficiency following SARS-CoV-2 infection: a rare pituitary complication
Pascoe Mannion1, Edward Jude1,2,3
1Department of Endocrinology, Tameside and Glossop Integrated Care, NHS Foundation Trust , Ashton-under-Lyne, UK.
Summary:
We describe a rare case of arginine vasopressin deficiency (AVP-D) in a female in her 40s that developed two weeks following symptomatic COVID-19 infection. Symptoms included polydipsia, nocturia and polyuria of 9.1 L per day. A water deprivation test demonstrated an ongoing high urine output despite increasing plasma osmolality, confirming the diagnosis. Desmopressin was commenced with good effect and titrated to clinical response. This demonstrates the importance of awareness of potential pituitary complications following COVID-19 infection, including AVP-D.
Related Concept Videos
Cerebral Edema ll: Pathophysiology
Coronavirus
Respiratory Syncytial Virus Disease
Heart Failure II: Pathophysiology


